Clinical trial findings are becoming ever more important in today’s world as consumers are looking beyond label claims and are actively reading up on the health benefits and evidence of ingredients used in immunity products, according to an expert panel.
2020 was a year of changing business practices, challenged global supply chains, and skyrocketing sales of dietary supplements and functional foods as consumers took more control of their own health and wellness.
The supplementation of a formulation containing myo-inositol, probiotics, and micronutrients before and during pregnancy could reduce preterm birth, according to a study conducted in Singapore, New Zealand, and UK.
Yiling Pharmaceutical, the company behind TCM/dietary supplement product Lianhua Qingwen, said revenue from its overseas market was up 918.37 per cent in FY2020, after the product was officially recognised by the China authorities as a COVID-19 standard...
Giving huge doses of vitamin D to treat COVID-19 patients has been the protocol in certain parts of the world, but the more urgent need could be addressing underlining deficiency, says the guest who stars in the 16th episode of our NutraChampion podcast.
South Korea will start the third phase of its mandatory traceability programme for special purpose foods, while international brands selling co-enzyme Q10, fish oil and melatonin into China for the first time will still need to enter the market via the...
New regulations in Australia is making research on the role of complementary medicine, including Chinese medicine, to manage chronic diseases more attractive, according to a prominent researcher who stars in the 15th episode of our NutraChampion podcast.
China’s reduction of import tariffs, including supplement products such as fish oil soft gel capsules and Food for Special Medical Purposes (FSMPs), will make both imports and local production more competitive, according to industry experts.
See January's 10 most read stories, including new data on how the gut microbiome is linked to severity of COVID-19, Indian firm Windlas Biotech's launch of an artemisinin supplement as an adjunctive to COVID-19 treatment and more.